OTCPicks.com Daily Market Movers Digest Midday Report for Friday, August 15th LLSR, QMCI, MITI, ETLT, CWSI

Our Stocks to Watch today include Lantis Laser Inc. (OTC: LLSR), QuoteMedia Inc. (OTCBB: QMCI), Micromet Inc. (Nasdaq: MITI), Eternal Technologies Group Inc. (OTCBB: ETLT) and China Wind Systems Inc. (OTCBB: CWSI).

LANTIS LASER INCORPORATED (OTC: LLSR)

Lantis Laser was formed to commercialize the application of novel technologies in the dental industry. The criteria for selected products include competitive edge, exclusivity and large market potential. Lantis is currently in Phase 2 development, moving through beta systems, product development and application for FDA clearance and plans to launch the OCT Dental Imaging System™ in the first quarter of 2009. Lantis has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory (exclusive); LightLab Imaging (non-exclusive) and AXSUN (exclusive). To find out more about Lantis Laser, visit www.lantislaser.com.

QUOTEMEDIA INCORPORATED (OTCBB: QMCI)

QuoteMedia, Inc. is a leading software developer and provider of real-time streaming financial market information, decision-support, news and research solutions to brokerage, financial services companies, business and media corporations. Among its many leading-edge products lines, the Company offers data feeds, news, dynamic market content solutions, interactive stock research tools, financial applications and real-time wireless applications. QuoteMedia provides data and services for companies such as the NASDAQ, the OTCBB, Dow Jones & Company, Forbes.com, Scotia Capital, Business Wire, Southwest Securities, Regal Securities, FBR Direct, Broadridge Financial Solutions, Inc., AIM Trimark, Zacks Investment Research, ChoiceTrade, QTrade, Schaeffer's Investment Research, Automated Financial Systems, WallStreet*E, and others. For more information, visit www.quotemedia.com.

MICROMET INCORPORATED (NASDAQ: MITI)

"Up 19.72% in morning trading"

Micromet, Inc., a biopharmaceutical company, develops antibodies for the treatment of cancer, inflammation, and autoimmune diseases. Its products under preclinical development include MT103 that is developed using BiTE antibody technology platform, which is being evaluated in a phase II clinical trial for the treatment of patients with acute lymphoblastic leukemia and in a phase I clinical trial for the treatment of patients with non-Hodgkin's lymphoma; adecatumumab, a clinical stage human monoclonal antibody, which targets epithelial cell adhesion molecule expressing solid tumors; and MT293, a phase I clinical trial product for the treatment of patients with cancer. The company is also developing adecatumumab in a phase Ib clinical trial, evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. Its products also include MT110, a BiTE antibody for EpCAM-expressing tumors; MT111, a preclinical stage product for the carcinoembryonic antigen, which is expressed in various tumors, such as colorectal carcinoma, lung adenocarcinoma, mucinous ovarian carcinoma, and endometrial adenocarcinoma; EphA2 BiTE antibody, which is in preclinical stage for the treatment of cancers; MCSP BiTE antibody, a preclinical product for the treatment of melanoma; MT293, a Phase I clinical trial product for the treatment of solid tumors; MT228, a preclinical product for melanoma; and MT203 and MT204, which are in preclinical stage for inflammatory diseases. Micromet has strategic collaborations with MedImmune, Inc. for MT103; Nycomed for development of anti-GM-CSF antibodies; and Merck Serono Biopharmaceuticals S.A. for adecatumumab. The company is headquartered in Bethesda, Maryland.

ETERNAL TECHNOLOGIES GROUP INCORPORATED (OTCBB: ETLT)

"Up 14.75% in morning trading"

Eternal is a major agricultural genetics and biopharmaceutical R&D firm operating in China with the support of the Chinese Government. Eternal's animal breeding division has a strong asset base, cash position and net income. Eternal has become one of China's leading institutions for biopharmaceutical and biotech research, pure breed cultivation and breed stock production. The Company has secured a key market niche by commercializing gene engineering technologies and providing superior breeding stock, allowing China's citizens the ability to improve their living standards. With the world's largest population, a double-digit national growth rate and entry into the WTO, Eternal Technologies has a playing field set for tremendous opportunity. As a prominent player in the agricultural genetics industry, cash in the bank and an untapped market, Eternal has the potential to become a major player in China's national growth. For more information, visit www.eternaltechs.com.

CHINA WIND SYSTEMS INCORPORATED (OTCBB: CWSI)

"Up 5.68% in morning trading"

China Wind Systems supplies forged rolled rings to the wind power and other industries and industrial equipment to the textile and energy industries in China. With its newly finished state-of-the-art production facility, the Company is expected soon to significantly increase its shipment of high- precision rolled rings and other essential components primarily to the wind power and other industries. For more information on the Company, visit www.chinawindsystems.com.

About OTCPicks.com

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks.com has been compensated two hundred thousand restricted 144 shares from a third party for LLSR advertising and promotional services. We have received Internet data services from QuoteMedia (QMCI) in return for coverage on our site.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.